Neuronal injury and loss are recognized features of neuroinflammatory disorders, including acute and chronic encephalitides and multiple sclerosis; destruction of astrocytes has been demonstrated in cases of Rasmussen encephalitis. Here, we show that innate immune cells (i.e. natural killer [NK] and FC T cells) cause loss of neurons from primary human neuron-enriched cultures by destroying the supporting astrocytes. Interleukin 2-activated NK cells caused loss of astrocytes within 1 hour, whereas neurons were lost at 4 hours. Time-lapse imaging indicated that delayed neuron loss was due to early destruction of supporting astrocytes. Selective blocking of astrocyte death with anti-NKG2D antibodies reduced neuron loss, as did blocking of CD54 on astrocytes. FC T cells also induced astrocyte cytotoxicity, leading to subsequent neuronal displacement. In astrocytes, NK cells caused caspase-dependent fragmentation of the intermediate filament proteins glial fibrillary acidic protein and vimentin, whereas anti-CD3-activated T cells produced fragmentation to a lesser extent and without measurable cytotoxicity. Glial fibrillary acidic protein fragmentation was also demonstrated in lysates from chronic multiple sclerosis plaques but not from normal control white matter. These data suggest that nonmajor histocompatibility complex-restricted immune effector cells may contribute to neuron loss in neuroinflammatory disorders indirectly through injury of glia.
INTRODUCTION
Neuronal injury and loss are recognized features of neuroinflammatory disorders, including multiple sclerosis (MS) and acute and chronic encephalitides (1Y3). Although neuronal cell bodies and axons can express major histocompatibility complex (MHC) Type I in situ (4) , and they may be subject to antigen-and MHC-dependent axonal transection in vitro (5) , the restricted expression of MHC molecules on neurons raises the possibility of injury mediated by non-MHC-/antigen-dependent immune effector mechanisms. Studies of experimental autoimmune encephalitis (EAE) in MHC I-deficient mice indicate that cellular immunemediated injury in the CNS can occur in an MHCindependent manner (6, 7) . Although the precise mechanisms of cell-cell contact-dependent injury remain to be defined, neurons are susceptible to MHC-independent cytotoxicity mediated by adaptive T cells in vitro in mouse brain slices and in dissociated primary human fetal neuron cultures (8, 9) .
Astrocytes are recognized as important contributors to neuron survival and function because they influence a range of processes, including synaptic function, adenosine triphosphatase release, gap-junction communication, glutamate metabolism, and regulation of blood flow (10) . In Rasmussen encephalitis, it has been demonstrated that astrocytes and neurons are killed through contact with cytotoxic T cells (11, 12) . There is also indirect evidence that suggests that astrocyte injury and loss occur in MS lesions (13, 14) . This loss is consistent with studies indicating that astrocytes inhibit Schwann cell remyelination (15) . Macrophages containing glial fibrillary acidic protein (GFAP)-positive granules have also been seen in active MS plaques (16) . Moreover, bystander neuron loss was observed in an animal model in which astrocytes that selectively expressed A-gal were killed by specific T cells (17) , and in the EAE model, astrocyte injury is enhanced by loss of >B-crystallin, thereby worsening the disease outcome (18) .
Cells of the innate immune system use non-MHCrestricted mechanisms to mediate target cell injury. Natural killer (NK) cells and FC T cells are constituents of this system and have been identified in the CNS in cases of MS and encephalitis (19, 20) , as well as in EAE (21) . Previously, we reported that activated NK cells and FC T cells cause MHCindependent toxicity to oligodendrocytes and astrocytes in vitro (22, 23) . The cytotoxic effects can be partially inhibited by blocking NKG2D receptors expressed by these effector cells and the corresponding ligands (MICA,B and ULBP1,2,3) expressed by the glial cells. Previous reports indicate that peripheral rodent neurons are susceptible to NK cellYmediated cytotoxicity through an NKG2D-dependent mechanism, whereas CNS-derived hippocampus neurons lacked NKG2D-ligand expression and were resistant to NK cells (24Y26). Recently, we showed that primary human neurons derived from CNS tissue do not express NKG2D ligands even under proinflammatory conditions (22) . The presence of NKG2D ligands on a potential target is not entirely predictive, however, because NK cell effects are regulated by multiple receptor-ligand interactions, including engagement of lymphocyte function-associated antigen 1 receptors by CD54 on the target cell (27) .
In this study, we examined the cytotoxic potential of innate immune cells toward human neurons using a primary human culture system that contains a layer of supporting astrocytes. Using a combination of time-lapse imaging and conventional cytotoxicity assays, we demonstrate that NK cells cause neuronal displacement and subsequent detachment of neurons from primary human neuron-enriched cultures. The mechanisms of this neuronal injury seemed to be indirect and through injury of the supporting astrocytes. Blocking antibodies against NKG2D, the ligands of which are expressed by astrocytes but not neurons, prevented neuronal detachment. Blocking CD54 also attenuated astrocyte loss. FC T cells induced initial astrocyte cytotoxicity with subsequent displacement of neurons, whereas anti-CD3 antibody-activated T cells did not induce significant cytotoxicity over the time frame examined. The NK cells caused initial cleavage of the intermediate filament protein GFAP in vitro, as did the activated T cells, although to a lesser extent. We further observed that MS plaques contained more fragmented GFAP as compared with normal controls. We conclude that innate immune mechanisms may lead to astrocyte injury and subsequent neuronal responses.
MATERIALS AND METHODS

Fetal Human Neuron-Enriched Culture
Primary human neuronal cultures were established from fetal brain tissue (18Y24 gestational weeks) provided by the Albert Einstein College of Medicine Human Fetal Tissue Repository (Bronx, NY). These studies were approved by the institutional review boards of the Albert Einstein College of Medicine and McGill University. Preparation of fetal brain and subsequent neuron-enriched and pure astrocyte cultures were as previously described (28) . In brief, neurons were prepared using minimum essential medium (5% fetal calf serum) supplemented with 5-fluoro-2 ¶-deoxyuridine, and astrocytes were enriched in Dulbecco_s modified Eagle_s medium (10% fetal calf serum) by at least 3 passages.
Immune Cell Isolation
Peripheral blood mononuclear cells (PBMCs) were purified from normal adult donors using a Ficoll-Hypaque density gradient and cultured in RPMI 10% media, as previously described (22) . Peripheral blood mononuclear cells were stimulated for 3 days with 100 U/ml of interleukin (IL) 2 (Roche, Mannheim, Germany) or the anti-CD3 monoclonal antibody OKT3 at 1:80000. This dilution was determined to provide maximal activation by thymidine incorporation assays (data not shown). Non-adherent PBMCs were further purified by magnetic activated cell sorting according to manufacturer_s protocols (Miltenyi Biotec, Auburn, CA). In brief, NK cells were selected using the CD56-multisort kit, followed by depletion with anti-CD3 beads. T cells were isolated from the CD56-negative fraction by anti-CD3 beads. Expanded FC T cells were generated as previously described (29) . In brief, PBMCs from MS patients were cultured on anti-FC T-cell receptor (TCR)-coated plastic plates in RPMI 10%. On Day 2, IL-2 (50 U/ml) was added. On Day 5, the cells were harvested and cultured in AIM V media with fresh IL-2 for an additional 4 to 5 days. When purity was less than 90%, CD4 and CD8 cells were eliminated by complement lysis. Cells were used fresh within a week of complement lysis or stored frozen and used after thawing and culturing overnight with 100 U/ml of IL-2. All studies using blood-derived immune cells were approved by McGill University and University of Ottawa institutional review boards.
Immune-Neural Cocultures, Blocking Antibody Studies
For cytotoxicity assays, 0.5 Â 10 6 effector cells were added to 0.5 Â 10 6 neurons (which have 0.8 Â 10 5 astrocytes) in 24-well plates to achieve a 1:1 effector-totarget (E-T) ratio. For antibody blocking studies, NK cells were preincubated with the indicated antibody for 1 hour. The immune cells were added to neuronal cultures at a 1:2 E-T ratio for 4 hours without further washing. Concentrations used were 40 Kg/ml for anti-NKG2D (Amgen, Inc., Seattle, WA), 40 Kg/ml of anti-CD54 (Chemicon, Temecula, CA), or 40 Kg/ml immunoglobulin G1-control (eBioscience, San Diego, CA).
Immunocytochemical Staining and Cell Counting
Cell cultures on coverslips were fixed and stained with antibodies and Hoechst as previously described (28) . Fluorescence images were obtained with a 40Â objective on a Zeiss Axiovert S100 system (Oberkochen, Germany). Cells from 5 images per group were counted using Image J cell manual counter plug-in (National Institutes of Health, Bethesda, MD). The t-test was performed between control and experimental groups. For confocal microscopy, a 63Â oil objective on a Zeiss LSM 510-meta was used. The optical thickness was less than 1 Km for each channel. For Z-stacks, 40 consecutive images (0.25-Km thickness) were reconstructed with Zeiss LSM 510 software. Antibodies used were GFAP-Cy3 (clone G-A-5) at 1:1000 and AIII-tubulin (monoclonal antibody SDL.3D10) used at 1:400 (both from SIGMA, Mississauga, Ontario, Canada), and these were detected with anti-mouse Alexa488 secondary (Invitrogen, Burlington, Ontario, Canada).
Flow Cytometry Analysis
Neuron cultures were detached with 1Â trypsin for 5 minutes at 37-C. Surface and intracellular stainings were performed as previously described (22) . The following conjugated primary mouse antibodies were used at 1:20 dilution: CD3-fluorescein isothiocyanate, CD56-PE, FC TCR-allophycocyanin, CD8-fluorescein isothiocyanate, MHC I-PE, CD54-allophycocyanin, and the corresponding isotype-matched conjugated control antibodies were used at equal concentration as the primary antibodies (all from BD Biosciences, San Diego, CA). For flow cytometry, mouseanti-GFAP-Alexa488 (monoclonal antibody 13117719; Invitrogen) was used at 1:600, and anti-AIII-tubulin used at 1:400 was detected with goat anti-mouse Alexa546 secondaries (Invitrogen) used at 1:1000.
Time-Lapse Imaging Studies
Neuron-enriched cultures were prepared on poly-L lysine-coated 35-mm culture dishes containing 1.5 Â 10 6 neurons to which 0.5 Â 10 6 immune cells were added. Neuronal cultures were preincubated with carboxy fluorescein succinimidyl ester (CFSE; Sigma, Mississauga, Ontario, Canada) at 1:2000 for 10 minutes at 37-C in serum-free media then washed twice with minimum essential medium 5%. Immune cells (NK cells, FC T cells, >A T cells) were preincubated with DiI (Invitrogen) at 1:500 for 10 minutes at 37-C in minimum essential medium 5% and washed twice with PBS. Samples were maintained at 37-C and 5% CO 2 in a humidified chamber, whereas fluorescent images were acquired with 20Â objective every 2 minutes for 2 hours using Northern Eclipse software (Empix Imaging, Mississauga, Ontario, Canada). To quantify individual cell dynamics, custom-made routines and open-source functions (30) were written in Matlab 7 using the Image Processing Toolbox. The trajectories corresponding to each individual cell were extracted from the time-lapse movie. The total travel distance of the cells was obtained by summing their absolute displacement between frames. The average velocity was calculated by dividing the movie frame rate and the average displacement per frame of each trajectory. The t-test was performed between average neuron velocities in the NKtreated and the T-cell-treated neuron cultures.
Analysis of Intermediate Filament Fragmentation
Primary human fetal astrocytes were cultured in 6-well plates to confluence. Z-VAD-fmk (Chemicon) or dimethyl sulfoxide (control) was added for 1 hour prior to addition of stimuli and maintained during the incubation. Staurosporine (Sigma) was used at 2 Kg/ml. Immune cells were added at a 1:1 ratio for 2 hours. Prior to lysis, cocultures were washed once with PBS, and adherent cells were removed by trypsination. Cells were lysed using 1.0% Triton Xcontaining lysis buffer, as previously described (28) . Postmortem brain samples from tissue donors without CNS disease and patients diagnosed clinically as having chronic MS and confirmed by neuropathologic examination were obtained from the NeuroResource tissue bank, Institute of Neurology, London, UK (Table) . Multiple sclerosis plaques and normal control white matter samples were dissected from snap-frozen tissue blocks that had been screened with oil red O and hematoxylin staining. The 3 plaques were all chronic because they were hypocellular with few or no oil red O-positive macrophages. The appropriate consent and ethical approvals were obtained by the tissue bank, and the studies were performed in accordance with the McGill University Health Centre research ethics board. Approximately 250 mm 3 of tissue was homogenized in radioimmunoprecipitation assay buffer (20 mmol/L of Tris, pH 7.5, 150 mmol/L of NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mmol/L of diaminoethanetetraacetic acid, 0.1% sodium dodecyl sulfate, 100 mmol/L of phenylmethylsulfonyl fluoride, 1 Kmol/L of sodium orthovanadate, 5 Kmol/L of EDTA (pH 7.4), and 1 Kg/mL each of aprotinin, phenylmethylsulfonyl fluoride, leupeptin, and pepstatin). Homogenization was done using a Caframo BDC 3030 stirrer (Caframo, Wiarton, Ontario, Canada) for 10 strokes at 900 rpm. Protein concentrations were assessed using a bicinchoninic acid assay kit (Pierce Biotechnology, Rockford, IL), and 20 Kg of total protein was loaded. Sodium dodecyl sulfatepolyacrylamide gel electrophoresis and Western blotting were performed as previously described (28) . Antibodies used to 
RESULTS
Primary Human Neuron-Enriched Cultures Contain a Layer of Supporting Astrocytes
As a source of primary human neurons, we used fetal neuron-enriched cultures, which typically contain a mixture of neurons and astrocytes (9, 31, 32) . Double staining for GFAP, an intermediate filament protein selectively expressed by astrocytes, and AIII-tubulin, a marker of neurons, showed that astrocytes form a dense network of processes underneath the neurons (Figs. 1A, B) . The neurons made up an average of 84% (SD T 10; n = 9) of the cells in neuron-enriched cultures. Neurons in astrocyte-depleted cultures prepared by cell sorting failed to extend neurites and did not survive well even in astrocyte-conditioned media (data not shown). We further characterized the properties of neuron-enriched cultures by flow cytometry. Two distinct populations (i.e. a large, granular, GFAP-positive population and a smaller AIIItubulin-positive population) consistent with astrocytes and neurons were observed (Fig. 1C) . The neurons also expressed neuronal cell adhesion molecule (CD56), microtubuleassociated protein 2, neurofilament M, and neurofilament H (data not shown). As reported previously (9), the astrocytes expressed MHC I, whereas the neurons were negative for MHC I. Astrocytes also expressed the adhesion molecule CD54, and neurons expressed low levels of CD54 (Fig. 1C) .
IL-2-Activated NK Cells Cause Neuronal Displacement and Subsequent Detachment by Injuring Supporting Astrocytes
We conducted time-lapse imaging to monitor the cellcell interactions between neural and immune cells. Primary neuron-enriched cultures were live-labeled with the nonselective cytoplasmic marker CFSE (green). To validate our ability to discriminate between the morphology of neurons and astrocytes, CFSE-labeled cells were fixed and stained for GFAP. As seen in Figure 2A , the neurons stained brightly for CFSE and had small, round morphologies, whereas the GFAP-positive astrocytes had larger asymmetric cell bodies and displayed a lower intensity of CFSE staining. The differences in shape and CFSE intensity between neurons and astrocytes permitted tracking of the trajectories of neuronal cell bodies during the time-lapse imaging period. As illustrated in Figure 2B , neurons became displaced when incubated with IL-2-activated NK cells for 2 hours. In contrast, the average velocity of neuron cell bodies during T-cell incubation was lower than the average velocity of neurons in the NK cell incubation (Figs. 2C, D) . The purity of the NK and T-cell preparations is shown in Figure 3B . We further examined the time-lapse movies for evidence of astrocyte loss. As shown in Figure 2E , many of the astrocytes present in the first frame (2 minutes) could not be found in the final frame (122 minutes). The disappearance of astrocytes occurred within minutes and was associated with a concomitant displacement of the surrounding neurons (Fig. 2F) . The NK cells, labeled with the membrane marker DiI, contacted the neuron-enriched culture within minutes after addition and remained relatively stationary, whereas DiI-labeled T cells were motile throughout the imaging period (data not shown). The complete time-lapse movie of the NK cell/neuronal coculture is included as supplementary material (NKneuron.avi).
To support the time-lapse observations that NK cells primarily target the glial cells, we quantified the numbers of remaining neurons and astrocytes after treatment with IL-2-activated NK cells. After 1 hour, there was a significant loss of astrocytes but not neurons, whereas after 4 hours, the NK cells caused a greater than 75% reduction in astrocytes and neurons (Fig. 3A) . The late loss of neurons can be interpreted as either a delayed killing of neurons or that the neurons detached as a result of the earlier astrocyte death. To discriminate between these possibilities, we selectively blocked astrocyte lysis in the neuron-enriched cultures by blocking the NKG2D receptor on NK cells. NKG2D ligands are present on human fetal astrocytes, but not neurons (22) . As shown in Figure 4 , NKG2D blockade inhibited astrocyte loss in the neuron-enriched culture and, additionally, significantly prevented neuronal detachment. We also evaluated the contribution of CD54 expressed by astrocytes (Fig. 1) . CD54 blockade prevented astrocyte loss, although the extent of astrocyte protection was associated only with a trend toward prevention of neuron detachment (Fig. 4) . The isotypematched control antibody did not have an effect on basal killing as determined by chromium release assays on U251 glioma cytotoxicity (data not shown).
FC T Cells Cause Neuron Displacement and Astrocyte Loss
The relative abundance of FC T cells in MS lesions led us to examine the impact of this cell type on primary neuronenriched cultures. We first compared the effects of FC T cells and NK cells on the neural cultures using time-lapse imaging. With this technique, we found that FC T cells activated with anti-FC TCR antibodies and IL-2 caused a greater displacement of neuronal cell bodies compared with that of neurons under control conditions (Fig. 5A) . The magnitude of displacement caused by FC T cells was lower than that caused by activated NK cells (Fig. 5A) . Next, we quantified the total number of neural cells remaining in the culture after 4 hours of incubation. FC T cells caused a partial reduction in astrocytes but did not cause a significant reduction in neurons, whereas NK cells resulted in loss of both astrocytes and neurons (Fig. 5B) . The FC T cells, which were expanded to a high level of purity from blood using anti-FC TCR antibodies, expressed low levels of CD8, and a proportion of them expressed CD56 (Fig. 5C ). The mechanism of neuronal injury caused by FC T cells seems qualitatively similar to that caused by NK cells, although the latter cell type seems to be more potent in causing the loss.
Fragmentation of Intermediate Filaments in Astrocytes Exposed to NK Cells In Vitro and in MS Plaques
To link our in vitro studies with in situ observations, we used GFAP fragmentation as a readout of astrocyte degeneration, as has been described recently in the Alzheimer disease literature (33) . In Figure 6 , we demonstrate that staurosporine caused GFAP fragmentation in primary human astrocytes, and that this was inhibited by the pan caspase Figure 3 . An effector-to-target ratio of 1:2 resulted in 50% astrocyte loss after 4 hours. NKG2D and CD54 blockade partially prevented astrocytes loss. NKG2D blockade prevented neuron loss. *, p G 0.01 compared with ISO block (SE shown); †, p G 0.05, ‡, p G 0.01 compared with basal conditions. These data were pooled from 7 experiments.
inhibitor Z-VAD-fmk. Interleukin 2-activated NK cells caused GFAP fragmentation at levels comparable to staurosporine, whereas T cells isolated from anti-CD3-stimulated PBMCs caused a lesser extent of GFAP fragmentation (Fig. 6) . In all cases, the immune-mediated GFAP fragmentation was prevented by Z-VAD-fmk, indicating that the immune cells induce a caspase-mediated cleavage of GFAP. We also analyzed the related intermediate filament protein vimentin and observed similar caspase-dependent vimentin cleavage by staurosporine, IL-2-activated NK cells, and T cells, although this was to a lesser extent (Fig. 6) .
We next examined plaques from 3 MS cases for intermediate filament fragmentation using white matter from normal donors as a control. As shown in Figure 7 , the MS plaques analyzed all contained fragmented GFAP, whereas only 1 of the control cases had weak GFAP fragmentation. Vimentin was not fragmented in the MS plaques examined or in the normal control white matter (Fig. 6) . Vimentin fragmentation in the MS tissues was not observed, indicating that the fragmented GFAP was not the result of sample degradation. Glial fibrillary acidic protein has been shown to be stable for long periods in postmortem MS tissue (34) .
DISCUSSION
In this study, we used primary human neuronYenriched cultures as a model that reflects the supportive role of astrocytes toward neuronal function and survival in the CNS (35) . Our initial studies with NK cells showed a rapid lysis of astrocytes with subsequent loss of neurons. Partial loss of astrocytes was apparent at 1 hour, followed by nearly complete loss of astrocytes and neurons after 4 hours. We interpret the loss of neurons at 4 hours as a passive detachment due to loss of the supportive astrocytes. In support of this idea is the finding that selective inhibition of astrocyte lysis by blocking NKG2D receptors on NK cells resulted in a reduced loss of neurons. In the in vitro studies, caspase-dependent cleavage of intermediate filaments of astrocytes was an early event that preceded actual astrocyte destruction mediated by IL-2-activated NK cells; anti-CD3 activated T cells also induced GFAP fragmentation but without significant subsequent astrocyte cell loss. Our biochemical analysis of MS and control tissue samples showed that chronic MS plaques contain more fragmented GFAP than white matter from normal control cases.
The rapid loss of CFSE intensity in astrocytes detected by time-lapse imaging is consistent with an NK cell-mediated lysis/necrosis. We have previously shown that purified fetal astrocytes are killed by IL-2-activated NK cells within 4 hours using chromium release (36) . Others have shown that NK cell killing assays, which measure the release of fluorescent compounds from the cytoplasm, correlate well with chromium release assays (37) . Microscopic examination of cultures after 24 hours of incubation with IL-2-activated NK cells revealed that only cell debris remained (data not shown). Thus, detachment of neurons subsequent to astrocyte loss resulted in neuronal death. Although not tested in the present study, other inflammatory cytokines such as IL-21 and IL-15 have similar capacities to prime NK cells for killing (38) .
The antibody blocking data indicate that the immune effector-target interactions can involve multiple receptors, including NKG2D/NKG2D ligands and lymphocyte functionYassociated antigen 1/CD54 interactions. A lower (1:2) E-T ratio was used for the blocking studies due to the partial blocking effect of the antibodies (~10%). We have previously documented the NKG2D ligands MICA/B on oligodendrocytes but not astrocytes in MS lesions (22) , but have not ruled out the possibility that astrocytes in situ may express additional NK2D ligands, including ULBP1/2/3. In our neuron-enriched cultures, astrocytes expressed CD54 on their surface, and blocking CD54 provided partial rescue of astrocyte loss. CD54 can be a potent inducer of NK-cell degranulation in vitro by triggering lymphocyte functionassociated antigen 1 receptor-mediated signaling in NK cells (27) ; it has been shown to be expressed by astrocytes in MS lesions (39) . Because neither NKG2D blockade nor CD54 blockade was fully effective, NK cells may use additional receptor/ligand interactions.
We showed that FC T cells in vitro also induce initial destruction of astrocytes with subsequent displacement of neurons via the same mechanism we attribute to NK cells. The activated FC T cells did not result in a significant loss of neuron numbers in cytotoxicity assays. We attribute the lesser magnitude of neuronal injury caused by FC T cells compared with NK cells to a lower extent of astrocyte injury.
Natural killer cells and FC T cells have both been identified in active MS lesions and in EAE (19Y21). The overall contribution of NK cells to tissue injury in clinical and experimental autoimmune inflammatory disorders is difficult to evaluate because this cell population also serves a protective immune regulatory function (40, 41) . In murine models, NK cells have been implicated in direct mediation of injury to sympathetic and dorsal root ganglia neurons (24, 26), but not to CNS neurons (25) . The numbers of FC T cells in active inflammatory MS lesions is increased compared with chronic lesions and normal control cases (20) . Moreover, clonal expansion of FC T cells in lesions and the presence of candidate FC T-cell autoantigens of the heat shock protein family on astrocytes has been demonstrated (20) .
>A T cells have been reported to cause non-MHCrestricted neuron death in primary human neuron cultures (9) , but >A T cells purified from anti-CD3-activated PBMCs caused less displacement of neurons than NK cells and did not reduce the number of neurons after 24 hours. We speculate that the differences in >A T-cell effects in different studies may reflect differences in the age of the fetal material used (our cultures are derived from 18-to 24-gestational week tissues) or other differences in the culture conditions. We did note that such cells can induce measurable caspasedependent GFAP cleavage in astrocytes, although to a lesser extent than NK cells.
We observed that NK cells caused initial intermediate filament (GFAP and vimentin) cleavage in astrocytes with eventual astrocytic death. The fragmentation of these proteins can be inhibited with Z-VAD, a pan-caspase inhibitor. Staurosporine, a classical apoptotic insult, which has been used to trigger caspase-dependent GFAP cleavage in cell lines (33) , also caused GFAP and vimentin cleavage in primary human astrocytes. Staurosporine went on to kill the astrocytes (data not shown). Caspase-dependent GFAP fragmentation has been induced in animals using focal injection of the excitotoxin N-methyl-D-aspartate (42). We documented increased GFAP fragments in MS plaques compared with control CNS white matter, indicating that a degree of cytoskeletal degradation had occurred in astrocytes in these samples. The presence of intact vimentin in the plaques suggests that GFAP may be a more sensitive indicator of astrocyte injury.
Although the present study focuses on innate immune effector mechanisms, we cannot exclude the possibility that MHC-restricted T cells induce GFAP fragmentation in neuroinflammatory diseases. For example, T cells containing cytotoxic granules are near MHC I-expressing astrocytes in Rasmussen encephalitis (11) . It is not known, however, whether such cells recognize a specific autoantigen. We have shown that NKG2D-dependent mechanisms can contribute in vitro to both CD8 T-cell MHC-restricted (i.e. alloantigen reactive) cytotoxicity and through MHC-unrestricted mechanisms (22) . It has been shown that adaptive >A CD8 T cells exposed to proinflammatory conditions, especially IL-15, can acquire the capacity to mediate non-MHC-restricted target injury via NKG2D-dependent mechanisms (43) . Thus, either innate cells or adaptive immune cells with innate immune cell-like characteristics might bypass MHC restriction and induce neural cell injury in neuroinflammatory disorders.
